Informa’s 11-insider buy cluster and the Clarion pivot

UK events are still getting paid for

The UK events trade has not gone back to being a nostalgia business. It is still a cash business, and the market is still paying for companies that can fill halls, sell sponsorship, and keep the calendar busy when the macro stops cooperating. That is the frame here. The broader experience economy in the UK was valued at £140 billion and was projected to grow around 5% in 2026, while business events alone were estimated to contribute £33.6 billion annually. Those are not small numbers, and they explain why live events names keep drawing attention even when the rest of the media stack looks tired.

The comparison set matters because it shows how differently the market prices adjacent models. RELX trades on a richer multiple than Informa, with a normalized P/E of 20.73 versus Informa’s 25.52 in the cited snapshot, while Pearson sits lower at 18.58. On price to sales, RELX is at 5.08, Informa at 2.77, Pearson at 2.25. RELX and Wolters Kluwer have broader information-services footprints and more margin stability in some segments. Pearson is still wrestling with its own portfolio choices. Informa is the one leaning hardest into live B2B events, and that makes the stock more exposed to attendance, sponsorship, and deal flow, but also more levered to a clean operating story when the calendar cooperates.

A stock that is trying to look simpler than it used to

Informa has been doing two things at once. It has been buying scale in live events, and it has been trying to make the rest of the group less distracting. The acquisition of Clarion Events for £2.24 billion sits inside that logic, and so does the announced separation of Taylor & Francis. The company wants to look more like a focused international B2B events business and less like a mixed bag of publishing, digital services, and exhibitions. That is a strategic choice, not a cosmetic one.

The market has some reason to listen. The FTSE 100 closed at 10,656.28 on 12 October, up about 1% on the day, with banks and defensives helping the tape. The Bank of England policy rate was 3.75%, oil prices were elevated, and softer US jobs data had already taken some heat out of near-term rate-hike expectations. In that kind of market, investors tend to reward businesses that can show pricing power and recurring demand without needing a perfect macro backdrop. Informa is trying to present itself exactly that way.

The share price action was not euphoric. Informa closed at 874p on 12 October after trading between 860.20p and 899.20p. That matters because the insider buying landed at 860p, right near the lower end of that range and just below the close. The stock was not being bought in a panic, but it was also not being bought after a clean breakout. That is a more useful read than pretending the market gave the directors a gift.

The filing: 11 insiders, one price, and a very specific moment

The filing itself is the hook, but only because of what it sits beside. On 12 October 2026, multiple Informa directors and PDMRs disclosed purchases of new ordinary shares at 860p each as part of a £940 million equity placing and retail offer completed earlier that month. The transactions were executed on 6 October and admitted to trading on 8 October. The names in the disclosure included Stephen A Carter, Thomas H. Glocer, Joanne Wilson, Gill Whitehead, Andrew Ransom, Catherine Levene, Maria Kyriacou, Louise Smalley, John Rishton, and others, all at the same placing price.

The uniformity matters. This was not a random scatter of opportunistic buys at different levels. It was a coordinated subscription into a financing tied to a corporate transaction. Stephen A. Carter, the Group Chief Executive, subscribed for a euro-normalised filing value of EUR 446,476.2256293296. Thomas H. Glocer did the same. Joanne Wilson, Gill Whitehead, Andrew Ransom, Catherine Levene, Maria Kyriacou, Louise Smalley, and John Rishton followed at smaller euro-normalised amounts, but the pattern is the point. This was a board and executive group showing up for the same capital raise.

Insiders Trades data gives that filing a display score of 55, and the rationale is straightforward enough. The chief executive filed, the trade sat inside a wide cluster, and the amount was tiny relative to the company’s market value. The filing value was also near EUR 446,476 for the chief executive, which is not a trivial number in absolute terms, even if it is small against a market cap of EUR 14.05 billion. That is the kind of detail that keeps the read grounded. You are not looking at a heroic personal bet. You are looking at a management team participating in the financing of a strategic move they already announced.

Why the cluster matters more than the headline number

The cluster is the real feature here, because it tells you how the board chose to behave around the Clarion funding. Insiders Trades data shows 11 distinct insiders in the same direction over the past quarter, with 12 recent declarations in the cluster picture. That is a broad enough group to matter, especially when it includes the chief executive, the chair, and the senior independent director. It is not the sort of thing you get from a single enthusiastic director trying to make a point.

The role mix also matters. The chief executive is the one our scoring weights most heavily. The chair and non-executives are not running the business day to day, but they are still putting capital into the same transaction at the same price. That makes the filing look less like a personal portfolio tweak and more like a governance signal around a deal the board wants the market to accept. You can read that as alignment, and that is fair. You should not read it as a guarantee that the acquisition will work. Those are different claims.

The historical cohort data is useful here, but only if you keep it in its lane. For the bucket of chief-executive buys at large-cap names, Insiders Trades data shows a 90-day win rate of 58.9% across 1,477 observations, with an average 90-day return of 5.68% and an average 365-day return of 51.08%. That is historical cohort data, not a forecast for Informa, and it is not a promise that this trade will behave the same way. It does tell you that chief executive buying in large caps has not been a dead signal in our sample. It also tells you nothing about whether this specific acquisition will earn its keep.

Clarion, Taylor & Francis, and the cleaner story Informa wants

The Clarion acquisition is the strategic center of gravity. Informa is funding a £2.24 billion purchase while also moving to separate Taylor & Francis, which is a clear sign that management wants the market to value the events business on its own terms. That is a classic portfolio move, but it is not a generic one. Informa is not just selling a non-core asset and calling it discipline. It is trying to sharpen the identity of the remaining group around B2B live events, exhibitions, and conferences.

That matters because the business mix has consequences for how the market prices the stock. Live events can be lumpy, but they can also be sticky once the calendar is established and the audience is paying. Academic publishing is steadier, but it does not necessarily get the same excitement multiple when the market is in a mood to reward focus. The board’s willingness to subscribe at 860p says they were prepared to back the transaction at the same price as outside buyers. That is not the same as saying they think the stock is cheap. It is saying they were willing to stand in the same queue.

Stephen A. Carter’s comment on the equity issue was blunt enough: the positive response reflected strong investor support for the acquisition of Clarion and the decision to focus Informa as a leading international B2B business. That is management framing, so you do not take it at face value. But it does tell you what the company wants the market to own. The question is whether the market will pay up for a more concentrated events platform once the deal is digested and the publishing separation is clearer.

Where the market can still trip this up

There are obvious risks here, and they are not abstract. The first is execution. A £2.24 billion acquisition is large enough to matter, and the financing was large enough to require a £940 million equity placing and retail offer. That means dilution, integration work, and a need to prove that the asset mix improves rather than complicates the earnings profile. If the events cycle softens, the market will not care that the board bought alongside everyone else at 860p. It will care about cash generation and leverage.

The second risk is that the stock is already being asked to carry a lot of narrative. Informa is trading on a cleaner story, but cleaner stories can become crowded stories. RELX has already earned a premium for its broader information-services model. Pearson has shown how hard it is to re-rate a business while it is still in transition. Informa sits between those two examples. It has more operating leverage than RELX and a less defensive profile, but it is trying to avoid Pearson’s long slog through portfolio simplification. That is a narrow path.

Insiders Trades data does not remove those risks. The fundamental screen in the dossier is not especially rich, with a score of 39, a value of 38, and quality of 41. That is not a disaster, and it is not a green light by itself. It simply says the company is not arriving at this transaction with a pristine fundamental backdrop. The market will decide whether the Clarion deal and the Taylor & Francis separation improve that picture over time. The filing only tells you the board was willing to buy into the plan.

What to watch after the 860p print

The next test is not whether the directors bought. They already did. The test is whether the market starts treating 860p as a floor for the strategic story or just as the price of admission to a more concentrated events group. If the shares hold above the placing level while the company keeps talking up the Clarion integration and the publishing separation, the filing will look better in hindsight. If the stock slips back below that level, the market will be saying the board’s participation was necessary but not sufficient.

You also want to watch how the company talks about the mix after the deal closes. Informa’s events-heavy pivot is the whole point of the transaction, and the market will want evidence that the new shape is improving visibility rather than just changing the label on the box. The UK events backdrop is still supportive, and the broader market is not hostile. But this is still a business that has to earn its multiple every quarter. That is the part that matters now, not the ceremonial comfort of a cluster filing.

The final read is simple enough. The directors bought at 860p into a financing tied to Clarion, the stock closed at 874p on the day, and the company is trying to present itself as a cleaner B2B events story in a market that still pays for focus. The filing fits the strategy, but the strategy still has to prove itself in the numbers.

Dig deeper: Informa PLC's full insider filing history.

This is not investment advice.